Retatrutide Shows Significant Weight Loss in Phase III Diabetes Trial | Retatrutide News

Retatrutide has shown significant weight loss benefits for people with diabetes in a Phase III trial. This highlights its potential as a treatment optio...
Clinical Trials · November 3, 2026